Terms: = Liver cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
131 results:
1. Neuroblastoma RAS viral oncogene homolog (n-ras) deficiency aggravates liver injury and fibrosis.
Zheng K; Hao F; Medrano-Garcia S; Chen C; Guo F; Morán-Blanco L; Rodríguez-Perales S; Torres-Ruiz R; Peligros MI; Vaquero J; Bañares R; Gómez Del Moral M; Regueiro JR; Martínez-Naves E; Mohamed MR; Gallego-Durán R; Maya D; Ampuero J; Romero-Gómez M; Gilbert-Ramos A; Guixé-Muntet S; Fernández-Iglesias A; Gracia-Sancho J; Coll M; Graupera I; Ginès P; Ciudin A; Rivera-Esteban J; Pericàs JM; Frutos MD; Ramos Molina B; Herranz JM; Ávila MA; Nevzorova YA; Fernández-Malavé E; Cubero FJ
Cell Death Dis; 2023 Aug; 14(8):514. PubMed ID: 37563155
[TBL] [Abstract] [Full Text] [Related]
2. CircHULC accelerates the growth of human liver cancer stem cells by enhancing chromatin reprogramming and chromosomal instability via autophagy.
Song S; Wang L; Jiang X; Liu X; Li S; Xie S; Lu D
Cell Signal; 2023 Sep; 109():110772. PubMed ID: 37321526
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of
Lastraioli E; Bettiol A; Iorio J; Limatola E; Checcacci D; Parisi E; Bianchi C; Arcangeli A; Iannopollo M; Di Costanzo F; Di Lieto M
Cells; 2023 May; 12(11):. PubMed ID: 37296579
[TBL] [Abstract] [Full Text] [Related]
4. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma.
Wen S; Zeng J; Zhong L; Ye J; Lai X
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):53-57. PubMed ID: 37114307
[TBL] [Abstract] [Full Text] [Related]
5. Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab.
Li S; Yuan L; Yue M; Xu Y; Liu S; Wang F; Liu X; Wang F; Deng J; Sun Q; Liu X; Xue C; Lu T; Zhang W; Zhou J
Cancer Imaging; 2023 Mar; 23(1):30. PubMed ID: 36964617
[TBL] [Abstract] [Full Text] [Related]
6. Contrast-enhanced CT parameters predict short-term tumor response in patients with hepatocellular carcinoma who received sequential combined anti-angiogenesis and immune checkpoint inhibitor treatment.
Feng Y; Zhang H; Ren Q; Li C; Liu S; Zheng C; Xia X
Eur J Radiol; 2023 May; 162():110784. PubMed ID: 36958125
[TBL] [Abstract] [Full Text] [Related]
7. The role of TBK1 in cancer pathogenesis and anticancer immunity.
Runde AP; Mack R; S J PB; Zhang J
J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
[TBL] [Abstract] [Full Text] [Related]
8. MRI-Derived Sarcopenia Associated with Increased Mortality Following Yttrium-90 Radioembolization of Hepatocellular Carcinoma.
Guichet PL; Taslakian B; Zhan C; Aaltonen E; Farquharson S; Hickey R; Horn CJ; Gross JS
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1561-1569. PubMed ID: 34089074
[TBL] [Abstract] [Full Text] [Related]
9. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.
Bolhuis K; Kos M; van Oijen MGH; Swijnenburg RJ; Punt CJA
Eur J Cancer; 2020 Dec; 141():225-238. PubMed ID: 33189037
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission.
Yi T; Luo H; Qin F; Jiang Q; He S; Wang T; Su J; Song S; Qin X; Qin Y; Zhou X; Huang Z
Cell Death Dis; 2020 Oct; 11(10):832. PubMed ID: 33028809
[TBL] [Abstract] [Full Text] [Related]
11. First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal liver Metastases.
Petrowsky H; Linecker M; Raptis DA; Kuemmerli C; Fritsch R; Kirimker OE; Balci D; Ratti F; Aldrighetti L; Voskanyan S; Tomassini F; Troisi RI; Bednarsch J; Lurje G; Fard-Aghaie MH; Reese T; Oldhafer KJ; Ghamarnejad O; Mehrabi A; Abraham MET; Truant S; Pruvot FR; Hoti E; Kambakamba P; Capobianco I; Nadalin S; Fernandes ESM; Kron P; Lodge P; Olthof PB; van Gulik T; Castro-Benitez C; Adam R; Machado MA; Teutsch M; Li J; Scherer MN; Schlitt HJ; Ardiles V; de Santibañes E; Brusadin R; Lopez-Lopez V; Robles-Campos R; Malagó M; Hernandez-Alejandro R; Clavien PA
Ann Surg; 2020 Nov; 272(5):793-800. PubMed ID: 32833765
[TBL] [Abstract] [Full Text] [Related]
12. Anti-tumor Properties of
Xie DP; Gong YX; Jin YH; Ren CX; Liu Y; Han YH; Jin MH; Zhu D; Pan QZ; Yu LY; Lee DS; Lee J; Kim J; Park YH; Hyun JW; Kwon T; Cui YD; Sun HN
Anticancer Res; 2020 Jul; 40(7):3819-3830. PubMed ID: 32620621
[TBL] [Abstract] [Full Text] [Related]
13. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on k-ras status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
[TBL] [Abstract] [Full Text] [Related]
14. A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma.
Yamano T; Kubo S; Tomita N
Cancer Med; 2020 May; 9(10):3337-3343. PubMed ID: 32168428
[TBL] [Abstract] [Full Text] [Related]
15. The role of miRNA -31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type k-ras metastatic colorectal cancer. Is it really the next best thing in miRNAs?
Sur D; Cainap C; Burz C; Havasi A; Chis IC; Vlad C; Milosevic V; Balacescu O; Irimie A
J BUON; 2019; 24(5):1739-1746. PubMed ID: 31786833
[TBL] [Abstract] [Full Text] [Related]
16. GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion.
Zhang W; Williams TA; Bhagwath AS; Hiermann JS; Peacock CD; Watkins DN; Ding P; Park JY; Montgomery EA; Forastiere AA; Jie C; Cantarel BL; Pham TH; Wang DH
Lab Invest; 2020 Jan; 100(1):16-26. PubMed ID: 31292541
[TBL] [Abstract] [Full Text] [Related]
17. Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.
Pascale RM; Peitta G; Simile MM; Feo F
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234428
[TBL] [Abstract] [Full Text] [Related]
18. EAA clinical practice guidelines-gynecomastia evaluation and management.
Kanakis GA; Nordkap L; Bang AK; Calogero AE; Bártfai G; Corona G; Forti G; Toppari J; Goulis DG; Jørgensen N
Andrology; 2019 Nov; 7(6):778-793. PubMed ID: 31099174
[TBL] [Abstract] [Full Text] [Related]
19. Partial response after treatment with Conversion chemotherapy: A case report of a patient with colon cancer and unresectable hepatic metastases.
Bu Z; Lu C; Yang X; Lai H; Jiang Y; Li Y; Lin Y; Qin Y; Xiao M; Cheng C; Liu Q
Medicine (Baltimore); 2019 Apr; 98(17):e15239. PubMed ID: 31027071
[TBL] [Abstract] [Full Text] [Related]
20. Tyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA-Induced Early Onco/Suppressor Gene Expression with Tissue-Specificity in Mice.
Gergely PA; Murnyák B; Bencze J; Kurucz A; Varjas T; Gombos K; Hortobágyi T
Biomed Res Int; 2019; 2019():8670398. PubMed ID: 30882001
[TBL] [Abstract] [Full Text] [Related]
[Next]
